[Fatter through lipids or water. Lipohyperplasia dolorosa versus lymphedema].
Lipohyperplasia dolorosa and lymphedema are completely different disease entities, which are both, however, classified under lymphology. While in lipohyperplasia dolorosa a congenital lipid distribution disorder leads to a high volume insufficiency and the corresponding clinical symptoms, lymphedema is characterized by a congenital transport incompetence of the vessels or acquired disorders of transport capacity. Both lymphedemas of different genesis are familial volume alterations of the affected regions and the increase in volume is irreversible if not exclusively still in stage I or II. According to current knowledge the solid increase in volume by lymphedema is due to a malfunctioning biomechanism by which the release of additional proteoglycans in the homeostasis system of the fluid in the interstital space plays an important role. Removal of this tissue and the sponge-like substance of proteoglycans is the aim of therapeutic approaches. Manual lymph drainage and compression can evacuate the sponge but not remove it. Lymphological liposculpture is a successful dermatosurgical measure even for secondary lymphedema. Reduction of the necessity of complex hemostasis therapy to 20% of the initial value and an adjustment of the affected extremity on the healthy side, represent a clear improvement in quality of life of patients. The same dermatosurgical method, lymphological liposculpture, has been known for many years to fulfil the successfully proven purpose for the treatment of lipohyperplasia dolorosa by the removal of subcutaneous fatty tissue, present as hyperplasia and not hypertrophy. Tenderness and the necessity for complex hemostasis therapy are no longer present or no longer necessary after lymphological liposculpture for lipohyperplasia dolorosa. This condition is permanent because the congenital fatty masses do not reoccur following surgical removal. Lipohyperplasia dolorosa is therefore curable by lymphological liposculpture. For secondary lymphedema a drastic improvement in quality of life of the patient can be achieved by this method which is demonstrated by the adjustment of symmetry of the extremities and reduction or even avoidance of complex hemostasis therapy.
Cornely
M E
ME
post@hautarzt-duesseldorf.de
D000274:Adiposis Dolorosa / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D050218:Body Fat Distribution; D003937:Diagnosis, Differential; D004322:Drainage; D045604:Extracellular Fluid / Q000502:physiology; D006706:Homeostasis / Q000502:physiology; D006801:Humans; D015187:Lipectomy / Q000379:methods; D008209:Lymphedema / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D011509:Proteoglycans / Q000378:metabolism; D019651:Plastic Surgery Procedures
D011509:Proteoglycans